Markets:

Overview

News

Currencies

International

Treasuries

Karyopharm Therapeutics Inc. - Common Stock (NQ:KPTI)

0.6705 -0.1317 (-16.42%)

Delayed Quote Updated: 4:00 PM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Karyopharm Therapeutics Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

Recap: Karyopharm Therapeutics Q1 Earnings ↗

May 04, 2023

Via Benzinga

Karyopharm Therapeutics Earnings Preview ↗

May 03, 2023

Via Benzinga

Ericsson, Johnson & Johnson, Goldman Sachs And Other Big Stocks Moving Lower On Tuesday ↗

April 18, 2023

U.S. stocks traded lower, with the Dow Jones dropping over 100 points on Tuesday. Here are some big stocks recording losses in today’s session.

Via Benzinga

Consolidated Communications, CRISPR Therapeutics And Other Big Stocks Moving Higher On Thursday ↗

April 13, 2023

U.S. stocks traded higher, with the Dow Jones gaining over 100 points on Thursday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Illumina, Seagen And Other Big Stocks Moving Higher On Monday ↗

March 13, 2023

U.S. stocks traded slightly lower, with the Nasdaq Composite dropping around 0.2% on Monday. Here are some big stocks recording gains in today’s session.

Via Benzinga

The Latest Analyst Ratings for Karyopharm Therapeutics ↗

February 22, 2023

Via Benzinga

Earnings Preview For Karyopharm Therapeutics ↗

February 14, 2023

Via Benzinga

Why Bank Shares Are Trading Lower? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

March 13, 2023

Gainers Provention Bio, Inc. (NASDAQ: PRVB) shares jumped 250.8% to $23.50 after Sanofi announced it will acquire the company for $25 per share in cash.

Via Benzinga

Karyopharm Therapeutics (KPTI) Q4 2022 Earnings Call Transcript ↗

February 15, 2023

KPTI earnings call for the period ending December 31, 2022.

Via The Motley Fool

Analyst Ratings for Karyopharm Therapeutics ↗

January 19, 2023

Via Benzinga

Karyopharm Therapeutics (KPTI) Q3 2022 Earnings Call Transcript ↗

November 04, 2022

KPTI earnings call for the period ending September 30, 2022.

Via The Motley Fool

Expert Ratings for Karyopharm Therapeutics ↗

September 09, 2022

Analysts have provided the following ratings for Karyopharm Therapeutics (NASDAQ:KPTI) within the last quarter:

Via Benzinga

Where Karyopharm Therapeutics Stands With Analysts ↗

September 09, 2022

Karyopharm Therapeutics (NASDAQ:KPTI) has observed the following analyst ratings within the last quarter:

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For January 19, 2023 ↗

January 19, 2023

Via Benzinga

National Instruments, Virgin Galactic And Other Big Stocks Moving Higher On Friday ↗

January 13, 2023

U.S. stocks traded slightly higher, with the Dow Jones gaining around 25 points on Friday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Karyopharm Therapeutics Earnings Perspective: Return On Capital Employed ↗

August 18, 2022

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

December 23, 2022

OnFriday, 143 stocks hit new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

December 14, 2022

On Wednesday, 115 stocks hit new 52-week lows.

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

December 12, 2022

Via Benzinga

RH, HUYA, Bilibili And Some Other Big Stocks Moving Lower On Monday ↗

December 12, 2022

U.S. stocks traded higher, with the Dow Jones jumping more than 200 points on Monday. Here are some big stocks recording losses in today’s session.

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

November 04, 2022

Gainers Incannex Healthcare (NASDAQ:IXHL) shares moved upwards by 30.7% to $5.19 during Friday's pre-market session. The market value of their outstanding shares is at $316.2 million.

Via Benzinga

Under Armour To Rally Over 13%? Here Are 5 Other Price Target Changes For Friday ↗

November 04, 2022

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For November 4, 2022 ↗

November 04, 2022

Upgrades

Via Benzinga

10 Best Medical Stocks Under $5 ↗

October 29, 2022

The medical industry is one of the most lucrative sectors globally, and it is one that sees the highest spending in terms of research and development, and breakthrough advances through keeping up the...

Via Talk Markets

Ryder System, Harrow Health And Other Big Gainers From Tuesday ↗

September 28, 2022

U.S. stocks closed mixed with the Dow Jones dropping around 125 points on Tuesday. Here is the list of some big stocks recording gains in the previous session.

Via Benzinga

HashiCorp, Pagerduty, Lululemon And Some Other Big Stocks Moving Higher In Today's Pre-Market Session ↗

September 02, 2022

Hollysys Automation Technologies Ltd. (NASDAQ: HOLI) surged 13.5% to $19.25 in pre-market trading. A consortium led by Hollysys Automation’s management is looking to take the US-listed company private...

Via Benzinga

Why Pagerduty Is Trading Higher By 9%; Here Are 28 Stocks Moving Premarket ↗

September 02, 2022

Gainers

Via Benzinga

Karyopharm Therapeutics: Q2 Earnings Insights ↗

August 04, 2022

Karyopharm Therapeutics (NASDAQ:KPTI) reported its Q2 earnings results on Thursday, August 4, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Daily Biotech Pulse: Liver Disease-Focused Gene Therapy Pact, Assembly Bio Stops HBV Infection Trial, X4 Pharma Looks For Partners ↗

July 21, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

August 02, 2022

Tuesday's session saw 63 companies set new 52-week lows.

Via Benzinga

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.